Clinical Trials Directory

Trials / Conditions / Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

12 registered clinical trials studyying Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 — 3 currently recruiting.

StatusTrialSponsorPhase
WithdrawnNeoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
NCT05296005
Ohio State University Comprehensive Cancer CenterPhase 1
RecruitingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno
NCT05041153
M.D. Anderson Cancer CenterEARLY_Phase 1
Active Not RecruitingChemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of
NCT04929392
City of Hope Medical CenterPhase 2
RecruitingRamucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv
NCT04660760
Academic and Community Cancer Research UnitedPhase 2
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso
NCT04460937
National Cancer Institute (NCI)Phase 1
RecruitingAvapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Sol
NCT04771520
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingPembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
NCT04522336
M.D. Anderson Cancer CenterPhase 1
CompletedUse of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esopha
NCT04097028
Roswell Park Cancer InstitutePhase 2
Active Not RecruitingPaclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
NCT04220827
M.D. Anderson Cancer CenterPhase 1
CompletedGenetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574
National Cancer Institute (NCI)—
CompletedIRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Ga
NCT03918499
City of Hope Medical CenterPhase 1 / Phase 2
Active Not RecruitingNivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer
NCT03776487
M.D. Anderson Cancer CenterPhase 2